Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cooper

Showing results (261-270 of 363) with videos related to

Pageof 37
Sort By:
The Journal of Infectious Diseases|November 1, 1994
Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversionM L Tsang, L A Evans, P McQueen, et al.
Journal of Neurovirology|December 1, 1995
Quinolinic acid production is related to macrophage tropic isolates of HIV-1B J Brew, J Corbeil, L Pemberton, et al.
AIDS (London, England)|July 14, 2000
A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 studyA Carr, J Chuah, J Hudson, et al.
Leukemia & Lymphoma|May 1, 1993
The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphomaM J Boyle, T B Sculley, R Penny, et al.
The Journal of Infectious Diseases|November 7, 1998
Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, multicenter study. Australian IL-2 Study GroupA Carr, S Emery, A Lloyd, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1999
Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy?P J Easterbrook, R L Goodall, A G Babiker, et al.
Journal of Clinical Microbiology|September 2, 2000
Hepatitis C virus core mutations reduce the sensitivity of a fluorescence enzyme immunoassayH Tokita, G R Kaufmann, M Matsubayashi, et al.
AIDS Research and Human Retroviruses|November 1, 1992
Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipientsM T Kyaw, L Hurren, L Evans, et al.
The Journal of Infectious Diseases|February 1, 1993
Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infantP Palasanthiran, J B Ziegler, G J Stewart, et al.
HIV Medicine|February 28, 2009
Poly-l-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-upD Carey, D Baker, K Petoumenos, et al.
Pageof 37

Showing results (261-270 of 363) with videos related to

Sort By:
Pageof 37
The Journal of Infectious Diseases|November 1, 1994
Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversionM L Tsang, L A Evans, P McQueen, et al.
Journal of Neurovirology|December 1, 1995
Quinolinic acid production is related to macrophage tropic isolates of HIV-1B J Brew, J Corbeil, L Pemberton, et al.
AIDS (London, England)|July 14, 2000
A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 studyA Carr, J Chuah, J Hudson, et al.
Leukemia & Lymphoma|May 1, 1993
The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphomaM J Boyle, T B Sculley, R Penny, et al.
The Journal of Infectious Diseases|November 7, 1998
Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, multicenter study. Australian IL-2 Study GroupA Carr, S Emery, A Lloyd, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1999
Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy?P J Easterbrook, R L Goodall, A G Babiker, et al.
Journal of Clinical Microbiology|September 2, 2000
Hepatitis C virus core mutations reduce the sensitivity of a fluorescence enzyme immunoassayH Tokita, G R Kaufmann, M Matsubayashi, et al.
AIDS Research and Human Retroviruses|November 1, 1992
Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipientsM T Kyaw, L Hurren, L Evans, et al.
The Journal of Infectious Diseases|February 1, 1993
Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infantP Palasanthiran, J B Ziegler, G J Stewart, et al.
HIV Medicine|February 28, 2009
Poly-l-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-upD Carey, D Baker, K Petoumenos, et al.
Pageof 37